PubRank

Anuradha Budhu

Author PubWeight™ 45.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009 6.13
2 EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2008 5.53
3 EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 2008 4.17
4 Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 2009 3.92
5 MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009 3.03
6 Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Res 2007 2.63
7 A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res 2010 2.59
8 Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. Nat Cell Biol 2005 2.15
9 Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Clin Cancer Res 2007 1.73
10 Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology 2011 1.68
11 Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. J Natl Cancer Inst 2007 1.58
12 Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology 2012 1.57
13 Cancer-associated molecular signature in the tissue samples of patients with cirrhosis. Hepatology 2004 1.41
14 Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol 2010 1.41
15 Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Clin Cancer Res 2013 1.31
16 Mammary carcinoma suppression by cellular retinoic acid binding protein-II. Cancer Res 2003 1.30
17 Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. Gastroenterology 2010 1.28
18 Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clin Cancer Res 2010 0.99
19 Effect of hepatitis C virus core protein on the molecular profiling of human B lymphocytes. Mol Med 2006 0.90
20 Future of molecular profiling of human hepatocellular carcinoma. Future Oncol 2007 0.89
21 High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells. Chem Biol Drug Des 2013 0.78